<?xml version='1.0' encoding='utf-8'?>
<document id="27388105"><sentence text="Reduction in serum concentration of valproic acid secondary to the intake of ibuprofen as an example of valproic acid auto-induction metabolism."><entity charOffset="36-49" id="DDI-PubMed.27388105.s1.e0" text="valproic acid" /><entity charOffset="77-86" id="DDI-PubMed.27388105.s1.e1" text="ibuprofen" /><entity charOffset="104-117" id="DDI-PubMed.27388105.s1.e2" text="valproic acid" /><pair ddi="false" e1="DDI-PubMed.27388105.s1.e0" e2="DDI-PubMed.27388105.s1.e0" /><pair ddi="false" e1="DDI-PubMed.27388105.s1.e0" e2="DDI-PubMed.27388105.s1.e1" /><pair ddi="false" e1="DDI-PubMed.27388105.s1.e0" e2="DDI-PubMed.27388105.s1.e2" /><pair ddi="false" e1="DDI-PubMed.27388105.s1.e1" e2="DDI-PubMed.27388105.s1.e1" /><pair ddi="false" e1="DDI-PubMed.27388105.s1.e1" e2="DDI-PubMed.27388105.s1.e2" /></sentence><sentence text="In 1998, an unexplained drug-drug interaction between valproic acid (VPA) and ibuprofen was reported"><entity charOffset="54-67" id="DDI-PubMed.27388105.s2.e0" text="valproic acid" /><entity charOffset="69-72" id="DDI-PubMed.27388105.s2.e1" text="VPA" /><entity charOffset="78-87" id="DDI-PubMed.27388105.s2.e2" text="ibuprofen" /><pair ddi="false" e1="DDI-PubMed.27388105.s2.e0" e2="DDI-PubMed.27388105.s2.e0" /><pair ddi="false" e1="DDI-PubMed.27388105.s2.e0" e2="DDI-PubMed.27388105.s2.e1" /><pair ddi="false" e1="DDI-PubMed.27388105.s2.e0" e2="DDI-PubMed.27388105.s2.e2" /><pair ddi="false" e1="DDI-PubMed.27388105.s2.e1" e2="DDI-PubMed.27388105.s2.e1" /><pair ddi="false" e1="DDI-PubMed.27388105.s2.e1" e2="DDI-PubMed.27388105.s2.e2" /></sentence><sentence text=" VPA has been considered a moderate inhibitor of several metabolic enzymes, but recently its inductive properties have been described, including the possibility of auto-induction"><entity charOffset="1-9" id="DDI-PubMed.27388105.s3.e0" text="VPA" /></sentence><sentence text=" Ibuprofen can displace VPA from the plasmatic protein, increasing its serum free concentration, and subsequently its pharmacological actions, including auto-induction"><entity charOffset="1-10" id="DDI-PubMed.27388105.s4.e0" text="Ibuprofen" /><entity charOffset="24-32" id="DDI-PubMed.27388105.s4.e1" text="VPA" /><pair ddi="false" e1="DDI-PubMed.27388105.s4.e0" e2="DDI-PubMed.27388105.s4.e0" /><pair ddi="false" e1="DDI-PubMed.27388105.s4.e0" e2="DDI-PubMed.27388105.s4.e1" /></sentence><sentence text=" The objective of this article is to describe a similar case and to contribute to the clarification of the underlying pharmacokinetic mechanisms" /><sentence text="" /><sentence text="A 29-year-old Spanish Caucasian male with schizophrenia was followed with steady-state trough serum concentrations of VPA and clozapine for 5 years, including 3 ibuprofen trials"><entity charOffset="118-121" id="DDI-PubMed.27388105.s7.e0" text="VPA" /><entity charOffset="126-135" id="DDI-PubMed.27388105.s7.e1" text="clozapine" /><entity charOffset="161-170" id="DDI-PubMed.27388105.s7.e2" text="ibuprofen" /><pair ddi="false" e1="DDI-PubMed.27388105.s7.e0" e2="DDI-PubMed.27388105.s7.e0" /><pair ddi="false" e1="DDI-PubMed.27388105.s7.e0" e2="DDI-PubMed.27388105.s7.e1" /><pair ddi="false" e1="DDI-PubMed.27388105.s7.e0" e2="DDI-PubMed.27388105.s7.e2" /><pair ddi="false" e1="DDI-PubMed.27388105.s7.e1" e2="DDI-PubMed.27388105.s7.e1" /><pair ddi="false" e1="DDI-PubMed.27388105.s7.e1" e2="DDI-PubMed.27388105.s7.e2" /></sentence><sentence text=" The main outcome variable was the concentration-to-dose (C/D) ratio, a measure of the ability to eliminate a drug" /><sentence text=" Independent sample Mann-Whitney U tests were performed to compare C/D ratios" /><sentence text="" /><sentence text="Five VPA C/D ratios, contaminated by VPA auto-induction occurring during or shortly after the two latter ibuprofen trials, were significantly lower (p&lt;0"><entity charOffset="105-114" id="DDI-PubMed.27388105.s11.e0" text="ibuprofen" /><entity charOffset="5-13" id="DDI-PubMed.27388105.s11.e1" text="VPA" /><entity charOffset="37-45" id="DDI-PubMed.27388105.s11.e2" text="VPA" /><pair ddi="false" e1="DDI-PubMed.27388105.s11.e1" e2="DDI-PubMed.27388105.s11.e1" /><pair ddi="false" e1="DDI-PubMed.27388105.s11.e1" e2="DDI-PubMed.27388105.s11.e2" /><pair ddi="false" e1="DDI-PubMed.27388105.s11.e1" e2="DDI-PubMed.27388105.s11.e0" /><pair ddi="false" e1="DDI-PubMed.27388105.s11.e2" e2="DDI-PubMed.27388105.s11.e2" /><pair ddi="false" e1="DDI-PubMed.27388105.s11.e2" e2="DDI-PubMed.27388105.s11.e0" /></sentence><sentence text="001) than the other 34 VPA C/D ratios of VPA not contaminated by auto-induction"><entity charOffset="23-25" id="DDI-PubMed.27388105.s12.e0" text="VPA" /><entity charOffset="41-43" id="DDI-PubMed.27388105.s12.e1" text="VPA" /><pair ddi="false" e1="DDI-PubMed.27388105.s12.e0" e2="DDI-PubMed.27388105.s12.e0" /><pair ddi="false" e1="DDI-PubMed.27388105.s12.e0" e2="DDI-PubMed.27388105.s12.e1" /></sentence><sentence text=" During the highest ibuprofen dose in the third trial, the patient had two very low clozapine C/D ratios, which were significantly lower than the other 26 clozapine C/D ratios (p=0"><entity charOffset="20-29" id="DDI-PubMed.27388105.s13.e0" text="ibuprofen" /><entity charOffset="84-95" id="DDI-PubMed.27388105.s13.e1" text="clozapine C" /><entity charOffset="155-166" id="DDI-PubMed.27388105.s13.e2" text="clozapine C" /><pair ddi="false" e1="DDI-PubMed.27388105.s13.e0" e2="DDI-PubMed.27388105.s13.e0" /><pair ddi="false" e1="DDI-PubMed.27388105.s13.e0" e2="DDI-PubMed.27388105.s13.e1" /><pair ddi="false" e1="DDI-PubMed.27388105.s13.e0" e2="DDI-PubMed.27388105.s13.e2" /><pair ddi="false" e1="DDI-PubMed.27388105.s13.e1" e2="DDI-PubMed.27388105.s13.e1" /><pair ddi="false" e1="DDI-PubMed.27388105.s13.e1" e2="DDI-PubMed.27388105.s13.e2" /></sentence><sentence text="021)" /><sentence text="" /><sentence text="Reduction in total VPA concentrations could be explained by ibuprofen displacing VPA from the plasma proteins, increasing the serum free VPA"><entity charOffset="60-69" id="DDI-PubMed.27388105.s16.e0" text="ibuprofen" /><entity charOffset="19-27" id="DDI-PubMed.27388105.s16.e1" text="VPA" /><entity charOffset="81-89" id="DDI-PubMed.27388105.s16.e2" text="VPA" /><entity charOffset="137-145" id="DDI-PubMed.27388105.s16.e3" text="VPA" /><pair ddi="false" e1="DDI-PubMed.27388105.s16.e1" e2="DDI-PubMed.27388105.s16.e1" /><pair ddi="false" e1="DDI-PubMed.27388105.s16.e1" e2="DDI-PubMed.27388105.s16.e0" /><pair ddi="false" e1="DDI-PubMed.27388105.s16.e1" e2="DDI-PubMed.27388105.s16.e2" /><pair ddi="false" e1="DDI-PubMed.27388105.s16.e1" e2="DDI-PubMed.27388105.s16.e3" /><pair ddi="false" e1="DDI-PubMed.27388105.s16.e0" e2="DDI-PubMed.27388105.s16.e0" /><pair ddi="false" e1="DDI-PubMed.27388105.s16.e0" e2="DDI-PubMed.27388105.s16.e2" /><pair ddi="false" e1="DDI-PubMed.27388105.s16.e0" e2="DDI-PubMed.27388105.s16.e3" /><pair ddi="false" e1="DDI-PubMed.27388105.s16.e2" e2="DDI-PubMed.27388105.s16.e2" /><pair ddi="false" e1="DDI-PubMed.27388105.s16.e2" e2="DDI-PubMed.27388105.s16.e3" /></sentence><sentence text=" This may induce the metabolism of VPA (and clozapine) and subsequently decrease their serum total concentrations"><entity charOffset="35-38" id="DDI-PubMed.27388105.s17.e0" text="VPA" /><entity charOffset="44-53" id="DDI-PubMed.27388105.s17.e1" text="clozapine" /><pair ddi="false" e1="DDI-PubMed.27388105.s17.e0" e2="DDI-PubMed.27388105.s17.e0" /><pair ddi="false" e1="DDI-PubMed.27388105.s17.e0" e2="DDI-PubMed.27388105.s17.e1" /></sentence><sentence text="" /></document>